about
Errors in CGAP xProfiler and cDNA DGED: the importance of library parsing and gene selection algorithmsInvolvement of Kallikrein-Related Peptidases in Normal and Pathologic ProcessesEmerging clinical importance of the cancer biomarkers kallikrein-related peptidases (KLK) in female and male reproductive organ malignanciesExpression of the human kallikrein genes 10 (KLK10) and 11 (KLK11) in cancerous and non-cancerous lung tissuesThe emerging roles of human tissue kallikreins in cancerGeneration and analysis of the expressed sequence tags from the mycelium of Ganoderma lucidummRNA profiling reveals determinants of trastuzumab efficiency in HER2-positive breast cancerDeciphering c-MYC-regulated genes in two distinct tissues.Human kallikrein 8 expression in salivary gland tumors.Evolutionary history of tissue kallikreinsThe KLK5 protease suppresses breast cancer by repressing the mevalonate pathwayThe use of EST expression matrixes for the quality control of gene expression dataDifferential expression of cancer associated proteins in breast milk based on age at first full term pregnancyActivation and enzymatic characterization of recombinant human kallikrein 8.Identification of differentially expressed genes in HPV-positive and HPV-negative oropharyngeal squamous cell carcinomas.Kallikrein-related peptidase 5 induces miRNA-mediated anti-oncogenic pathways in breast cancer.The tissue kallikrein family of serine proteases: functional roles in human disease and potential as clinical biomarkers.In silico gene expression analysis--an overview.NES1/KLK10 gene represses proliferation, enhances apoptosis and down-regulates glucose metabolism of PC3 prostate cancer cells.Circulating microRNA-92a and microRNA-21 as novel minimally invasive biomarkers for primary breast cancerKallikreins - The melting pot of activity and functionThe utility of breastmilk for genetic or genomic studies: a systematic review.Randomness and preserved patterns in cancer network.Decreased expression of kallikrein-related peptidase 13: possible contribution to metastasis of human oral cancer.Functional evidence that Drosha overexpression in cervical squamous cell carcinoma affects cell phenotype and microRNA profiles.KLK6-regulated miRNA networks activate oncogenic pathways in breast cancer subtypes.α2 Integrin-Dependent Suppression of Pancreatic Adenocarcinoma Cell Invasion Involves Ectodomain Regulation of Kallikrein-Related Peptidase-5.Glucocorticoid receptor-mediated expression of kallikrein 10 in human breast cancer cell lines.Overexpression of the human tissue kallikrein genes KLK4, 5, 6, and 7 increases the malignant phenotype of ovarian cancer cells.Clinical relevance of the deregulated kallikrein-related peptidase 8 mRNA expression in breast cancer: a novel independent indicator of disease-free survival.Expression of Human Kallikreins 4, 8, 10, 11 and 13 in Pleomorphic Adenomas and Mucoepidermoid Carcinomas.Clinical relevance of kallikrein-related peptidase 9, 10, 11, and 15 mRNA expression in advanced high-grade serous ovarian cancer.Diagnostic and prognostic biomarker potential of kallikrein family genes in different cancer types.Elevated tumor tissue protein expression levels of kallikrein-related peptidases KLK10 and KLK11 are associated with a better prognosis in advanced high-grade serous ovarian cancer patients
P2860
Q21284330-F89C94D0-DFED-45B7-8774-9E5588C54AEAQ26771266-E84EE54F-4FDF-42E1-917E-4BE77BC41DB5Q27007065-3B9BD02C-D8B2-4945-9CE4-A01C0E2EFEDCQ28248492-8E2E0E62-19AE-4B3D-A5A5-C1C29F309861Q28290701-F8120EC0-DB00-4827-9522-18058E59CB51Q28487471-01092D76-BD84-4CD7-9DFB-9A600371491AQ28543647-C26B1AB1-793A-430A-8B1A-36746BEC2216Q31031668-DF3C5D97-EE3E-4EF7-A3D9-8EA4E7A7D4AFQ33594956-699FC821-921F-4B8E-9347-F1EB855AA94DQ33745045-383FE014-B41B-4588-BD88-7CCD7B8F047DQ33757009-770D82CD-CFA1-40FF-AFAF-6B6EF917B235Q34193573-75A765ED-2264-441C-B23B-09BF09CDC093Q34205091-0ABEAE09-B774-434B-9971-F646452D8D04Q34541917-2297CF11-4426-4EA0-B605-A8530AF8044DQ34578434-1B7B17BB-328C-4EF3-8E50-60D778E7A2DAQ34781039-6C95D2F9-302E-4297-A091-4A780B76CA85Q35861497-1F6C8C17-D3A4-4BB1-AABE-02E4EE36C54BQ35971444-8CA93291-0256-4659-84DE-1F62A8191885Q36329646-A72EE88C-8B33-4C32-9F42-B9CE377BC40AQ36546638-1279E76D-D48E-4D88-9C38-CE987A6D9C2BQ36563056-FDECA4F7-CCB0-41B4-A681-A81482C0D99EQ36873385-808BA53B-A65B-4434-92E5-68A114802103Q37733223-5170117E-E937-4E18-8C1B-B3B57D47C788Q39201211-B13854B0-5848-4850-A7EF-9A8A4E3C751BQ39540562-1E51CB50-6894-4113-B0D4-91521030A776Q39839292-0133C2E0-DDBA-4070-9324-BA2F6394A7AFQ39988748-1A511867-671E-422F-8ECD-59772214AE89Q40067580-753CD163-A9E7-497A-A2B0-B358A2C5B67BQ40262739-2C7CF186-CD6C-4935-92BC-51DE9519F2CDQ40811309-1A08377C-B8ED-4299-BDF1-3FC4C6DF0BD0Q41466936-AA000ADF-C987-4331-B8DA-3CD73C4BB37CQ47098651-61A2892C-5761-4286-9A79-2AE75407033BQ54976872-50E6A5C4-0635-4385-A5D4-9BC3CCA1D59DQ57494113-6F445692-BBA4-4F4B-B8CA-4513F708997C
P2860
description
2004 nî lūn-bûn
@nan
2004 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Kallikrein gene downregulation in breast cancer.
@ast
Kallikrein gene downregulation in breast cancer.
@en
type
label
Kallikrein gene downregulation in breast cancer.
@ast
Kallikrein gene downregulation in breast cancer.
@en
prefLabel
Kallikrein gene downregulation in breast cancer.
@ast
Kallikrein gene downregulation in breast cancer.
@en
P2093
P2860
P356
P1476
Kallikrein gene downregulation in breast cancer.
@en
P2093
Diamandis EP
Polymeris ME
Soosaipillai A
P2860
P2888
P304
P356
10.1038/SJ.BJC.6601451
P407
P577
2004-01-01T00:00:00Z
P5875
P6179
1051758824